Theralase Technologies (TSXV:TLT) Other Operating Expense : C$0.02 Mil (TTM As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Theralase Technologies Other Operating Expense?

Theralase Technologies's Other Operating Expense for the three months ended in Mar. 2025 was C$0.01 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.02 Mil.

Theralase Technologies's quarterly Other Operating Expense increased from Sep. 2024 (C$-0.00 Mil) to Dec. 2024 (C$0.01 Mil) and increased from Dec. 2024 (C$0.01 Mil) to Mar. 2025 (C$0.01 Mil).

Theralase Technologies's annual Other Operating Expense declined from Dec. 2022 (C$0.05 Mil) to Dec. 2023 (C$0.05 Mil) and declined from Dec. 2023 (C$0.05 Mil) to Dec. 2024 (C$0.04 Mil).

Theralase Technologies Other Operating Expense Historical Data

The historical data trend for Theralase Technologies's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theralase Technologies Other Operating Expense Chart

Theralase Technologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

0.10

0.08

0.05

0.04

Theralase Technologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															0.01	-	-	0.01	0.01

Theralase Technologies Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.02 Mil.

Theralase Technologies Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Theralase Technologies's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Theralase Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Theralase Technologies Inc (TSXV:TLT) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

TLTFF:USA TTX:Germany TTX:Germany

Address

41 Hollinger Road, Toronto, ON, CAN, M4B 3G4

Website

https://www.theralase.com

Theralase Technologies Inc brings CLT to patients and personalized ACT to patients based on individual tissue characteristics. It is two separate reportable operating divisions; the Drug Division and the Device Division. The Drug Division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs), and activates them with proprietary and patent-pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The Device Division designs develops, manufactures, and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the Food and Drug Administration (FDA) for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions.

Executives

Matthew Thomas Perraton	Director
Roger John Dumoulin-white	10% Security Holder, Director, Senior Officer
Kristina Maria Hachey	Senior Officer
Arkady Mandel	Senior Officer
Guy John Anderson	Director
Shawn Shirazi	Senior Officer